糖化アルブミンアッセイの世界市場規模、シェア、産業動向分析レポート：用途別（2型糖尿病、1型糖尿病、糖尿病予備軍）、エンドユーザー別、地域別展望および予測、2023年～2030年

糖化アルブミンアッセイ市場規模は2030年には3億8,450万米ドルに達し、予測期間中のCAGRは8.4%の市場成長率で上昇すると予測されています。

さらに、COVID-19パンデミックは世界経済に大きな悪影響を及ぼしました。ほとんどすべての産業が、プラスにもマイナスにもパンデミックの影響を受けた。パンデミック発生の初期段階では、市場は小幅な影響を経験しました。規制当局による厳重な封鎖・閉鎖命令の施行とウイルスの増加により、人々が自由に場所を移動することが制限され、定期検診のために病院に通うことも制限されたため、市場の成長は低下しました。このため、パンデミック初期の数ヶ月間は市場の成長が止まっています。

しかし、米国糖尿病学会（ADA）と欧州糖尿病学会（EASD）はともに、2型糖尿病（T2DM）患者の血糖コントロールを「患者中心」に管理し、リスクとベネフィットのバランスを保ちながら、糖尿病患者個人の健康状態を正確に反映するGAなどのバイオマーカーのみを使用することを提唱しています。機器メーカーは、米国連邦規則により、機器の追加修正には510（k）申請書の提出が義務付けられているため、この市場を拡大する上で大きな障害に直面しています。規制状況の大幅な変化により、市場は困難に直面する可能性があります。

アプリケーションの展望

用途別に見ると、市場は糖尿病前症、1型糖尿病、2型糖尿病に区分されます。糖尿病前症セグメントは、2022年の市場でかなりの収益シェアを獲得しました。血糖値が正常値を超えて上昇するが、糖尿病に分類されるほど高くないものを糖尿病予備軍と呼ぶ。糖尿病予備軍を早期に発見することは、2型糖尿病の発症を予防または先延ばしするための生活習慣の改善や治療に取り組む上で極めて重要です。過去3ヶ月間の平均値を示すHbA1cのような他の検査と比較すると、糖化アルブミン測定は、糖尿病予備軍を早期に発見することができます。

エンドユーザー

エンドユーザー別では、市場はホスピタリティセンター、診断ラボ、その他に分類されます。2022年には、病院＆糖尿病治療センターセグメントが市場で最も高い売上シェアを占めました。このセグメントは、市場の著しい拡大を経験しており、その主な理由は、疾患の早期診断に重点が置かれているためです。また、ホスピタリティや糖尿病ケア機関は、糖尿病患者に合わせたケアを提供することに専念しています。血糖コントロールを追跡するための重要な診断検査である糖化アルブミン測定は、包括的な糖尿病ケアに重点を置いているため、これらのセンターで頻繁に実施されています。

地域別展望

地域別に見ると、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。2022年には、北米地域が市場で最も高い収益シェアを記録しました。糖尿病のような生活習慣病の罹患率の上昇と、効率的な糖尿病治療のための有用な政府プログラムが、北米市場の拡大の原因となっています。また、同地域のメディケイド、メディケア、民間医療保険会社は、医療保険の適用範囲を拡大することで、市場成長に大きく貢献すると予測されています。その他の市場促進要因としては、人口の高齢化、有益な政府政策のイントロダクション、より洗練されたアッセイなどが挙げられます。

目次

第1章 市場範囲と調査手法

• 市場の定義
• 目的
• 市場範囲
• セグメンテーション
• 調査手法

第2章 市場の概要

• 主なハイライト

第3章 市場概要

• イントロダクション
  • 概要
    • 市場構成とシナリオ
• 市場に影響を与える主な要因
  • 市場促進要因
  • 市場抑制要因
• ポーターファイブフォース分析

第4章 世界の糖化アルブミンアッセイ市場：用途別

• 世界の2型糖尿病市場：地域別
• 世界の1型糖尿病市場：地域別
• 世界の前糖尿病市場：地域別

第5章 世界の糖化アルブミンアッセイ市場：エンドユーザー別

• 世界の病院および糖尿病ケアセンター市場：地域別
• 世界の診断検査市場：地域別
• 世界のその他の市場：地域別

第6章 世界の糖化アルブミンアッセイ市場：地域別

• 北米
  • 北米の市場：国別
    • 米国
    • カナダ
    • メキシコ
    • その他北米地域
• 欧州
  • 欧州の市場：国別
    • ドイツ
    • 英国
    • フランス
    • ロシア
    • スペイン
    • イタリア
    • その他欧州地域
• アジア太平洋
  • アジア太平洋の市場：国別
    • 中国
    • 日本
    • インド
    • 韓国
    • シンガポール
    • マレーシア
    • その他アジア太平洋地域
• ラテンアメリカ・中東・アフリカ
  • ラテンアメリカ・中東・アフリカの市場：国別
    • ブラジル
    • アルゼンチン
    • アラブ首長国連邦
    • サウジアラビア
    • 南アフリカ
    • ナイジェリア
    • その他ラテンアメリカ・中東・アフリカ地域

第7章 企業プロファイル

• Asahi Kasei Pharma Corporation（Asahi Kasei Corporation）
• EKF Diagnostics Holdings plc
• Weldon Biotech India Private Limited
• Hzymes Biotechnology Co, Ltd.
• Beijing Strong Biotechnologies, Inc
• Abbexa Limited
• Biomatik Corporation
• Abnova Corporation
• Geno Technology, Inc
• Diazyme Laboratories, Inc（General Atomics）

第8章 糖化アルブミン測定市場の勝利は必須

LIST OF TABLES

• TABLE 1 Global Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 2 Global Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 3 Global Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 4 Global Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 5 Global Type 2 Diabetes Market by Region, 2019 - 2022, USD Thousands
• TABLE 6 Global Type 2 Diabetes Market by Region, 2023 - 2030, USD Thousands
• TABLE 7 Global Type 1 Diabetes Market by Region, 2019 - 2022, USD Thousands
• TABLE 8 Global Type 1 Diabetes Market by Region, 2023 - 2030, USD Thousands
• TABLE 9 Global Prediabetes Market by Region, 2019 - 2022, USD Thousands
• TABLE 10 Global Prediabetes Market by Region, 2023 - 2030, USD Thousands
• TABLE 11 Global Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 12 Global Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 13 Global Hospitals & Diabetic Care Center Market by Region, 2019 - 2022, USD Thousands
• TABLE 14 Global Hospitals & Diabetic Care Center Market by Region, 2023 - 2030, USD Thousands
• TABLE 15 Global Diagnostic Laboratory Market by Region, 2019 - 2022, USD Thousands
• TABLE 16 Global Diagnostic Laboratory Market by Region, 2023 - 2030, USD Thousands
• TABLE 17 Global Others Market by Region, 2019 - 2022, USD Thousands
• TABLE 18 Global Others Market by Region, 2023 - 2030, USD Thousands
• TABLE 19 Global Glycated Albumin Assay Market by Region, 2019 - 2022, USD Thousands
• TABLE 20 Global Glycated Albumin Assay Market by Region, 2023 - 2030, USD Thousands
• TABLE 21 North America Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 22 North America Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 23 North America Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 24 North America Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 25 North America Type 2 Diabetes Market by Country, 2019 - 2022, USD Thousands
• TABLE 26 North America Type 2 Diabetes Market by Country, 2023 - 2030, USD Thousands
• TABLE 27 North America Type 1 Diabetes Market by Country, 2019 - 2022, USD Thousands
• TABLE 28 North America Type 1 Diabetes Market by Country, 2023 - 2030, USD Thousands
• TABLE 29 North America Prediabetes Market by Country, 2019 - 2022, USD Thousands
• TABLE 30 North America Prediabetes Market by Country, 2023 - 2030, USD Thousands
• TABLE 31 North America Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 32 North America Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 33 North America Hospitals & Diabetic Care Center Market by Country, 2019 - 2022, USD Thousands
• TABLE 34 North America Hospitals & Diabetic Care Center Market by Country, 2023 - 2030, USD Thousands
• TABLE 35 North America Diagnostic Laboratory Market by Country, 2019 - 2022, USD Thousands
• TABLE 36 North America Diagnostic Laboratory Market by Country, 2023 - 2030, USD Thousands
• TABLE 37 North America Others Market by Country, 2019 - 2022, USD Thousands
• TABLE 38 North America Others Market by Country, 2023 - 2030, USD Thousands
• TABLE 39 North America Glycated Albumin Assay Market by Country, 2019 - 2022, USD Thousands
• TABLE 40 North America Glycated Albumin Assay Market by Country, 2023 - 2030, USD Thousands
• TABLE 41 US Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 42 US Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 43 US Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 44 US Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 45 US Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 46 US Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 47 Canada Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 48 Canada Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 49 Canada Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 50 Canada Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 51 Canada Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 52 Canada Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 53 Mexico Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 54 Mexico Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 55 Mexico Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 56 Mexico Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 57 Mexico Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 58 Mexico Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 59 Rest of North America Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 60 Rest of North America Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 61 Rest of North America Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 62 Rest of North America Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 63 Rest of North America Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 64 Rest of North America Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 65 Europe Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 66 Europe Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 67 Europe Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 68 Europe Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 69 Europe Type 2 Diabetes Market by Country, 2019 - 2022, USD Thousands
• TABLE 70 Europe Type 2 Diabetes Market by Country, 2023 - 2030, USD Thousands
• TABLE 71 Europe Type 1 Diabetes Market by Country, 2019 - 2022, USD Thousands
• TABLE 72 Europe Type 1 Diabetes Market by Country, 2023 - 2030, USD Thousands
• TABLE 73 Europe Prediabetes Market by Country, 2019 - 2022, USD Thousands
• TABLE 74 Europe Prediabetes Market by Country, 2023 - 2030, USD Thousands
• TABLE 75 Europe Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 76 Europe Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 77 Europe Hospitals & Diabetic Care Center Market by Country, 2019 - 2022, USD Thousands
• TABLE 78 Europe Hospitals & Diabetic Care Center Market by Country, 2023 - 2030, USD Thousands
• TABLE 79 Europe Diagnostic Laboratory Market by Country, 2019 - 2022, USD Thousands
• TABLE 80 Europe Diagnostic Laboratory Market by Country, 2023 - 2030, USD Thousands
• TABLE 81 Europe Others Market by Country, 2019 - 2022, USD Thousands
• TABLE 82 Europe Others Market by Country, 2023 - 2030, USD Thousands
• TABLE 83 Europe Glycated Albumin Assay Market by Country, 2019 - 2022, USD Thousands
• TABLE 84 Europe Glycated Albumin Assay Market by Country, 2023 - 2030, USD Thousands
• TABLE 85 Germany Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 86 Germany Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 87 Germany Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 88 Germany Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 89 Germany Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 90 Germany Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 91 UK Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 92 UK Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 93 UK Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 94 UK Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 95 UK Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 96 UK Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 97 France Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 98 France Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 99 France Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 100 France Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 101 France Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 102 France Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 103 Russia Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 104 Russia Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 105 Russia Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 106 Russia Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 107 Russia Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 108 Russia Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 109 Spain Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 110 Spain Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 111 Spain Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 112 Spain Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 113 Spain Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 114 Spain Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 115 Italy Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 116 Italy Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 117 Italy Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 118 Italy Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 119 Italy Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 120 Italy Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 121 Rest of Europe Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 122 Rest of Europe Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 123 Rest of Europe Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 124 Rest of Europe Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 125 Rest of Europe Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 126 Rest of Europe Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 127 Asia Pacific Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 128 Asia Pacific Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 129 Asia Pacific Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 130 Asia Pacific Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 131 Asia Pacific Type 2 Diabetes Market by Country, 2019 - 2022, USD Thousands
• TABLE 132 Asia Pacific Type 2 Diabetes Market by Country, 2023 - 2030, USD Thousands
• TABLE 133 Asia Pacific Type 1 Diabetes Market by Country, 2019 - 2022, USD Thousands
• TABLE 134 Asia Pacific Type 1 Diabetes Market by Country, 2023 - 2030, USD Thousands
• TABLE 135 Asia Pacific Prediabetes Market by Country, 2019 - 2022, USD Thousands
• TABLE 136 Asia Pacific Prediabetes Market by Country, 2023 - 2030, USD Thousands
• TABLE 137 Asia Pacific Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 138 Asia Pacific Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 139 Asia Pacific Hospitals & Diabetic Care Center Market by Country, 2019 - 2022, USD Thousands
• TABLE 140 Asia Pacific Hospitals & Diabetic Care Center Market by Country, 2023 - 2030, USD Thousands
• TABLE 141 Asia Pacific Diagnostic Laboratory Market by Country, 2019 - 2022, USD Thousands
• TABLE 142 Asia Pacific Diagnostic Laboratory Market by Country, 2023 - 2030, USD Thousands
• TABLE 143 Asia Pacific Others Market by Country, 2019 - 2022, USD Thousands
• TABLE 144 Asia Pacific Others Market by Country, 2023 - 2030, USD Thousands
• TABLE 145 Asia Pacific Glycated Albumin Assay Market by Country, 2019 - 2022, USD Thousands
• TABLE 146 Asia Pacific Glycated Albumin Assay Market by Country, 2023 - 2030, USD Thousands
• TABLE 147 China Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 148 China Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 149 China Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 150 China Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 151 China Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 152 China Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 153 Japan Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 154 Japan Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 155 Japan Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 156 Japan Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 157 Japan Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 158 Japan Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 159 India Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 160 India Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 161 India Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 162 India Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 163 India Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 164 India Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 165 South Korea Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 166 South Korea Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 167 South Korea Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 168 South Korea Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 169 South Korea Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 170 South Korea Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 171 Singapore Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 172 Singapore Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 173 Singapore Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 174 Singapore Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 175 Singapore Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 176 Singapore Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 177 Malaysia Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 178 Malaysia Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 179 Malaysia Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 180 Malaysia Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 181 Malaysia Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 182 Malaysia Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 183 Rest of Asia Pacific Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 184 Rest of Asia Pacific Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 185 Rest of Asia Pacific Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 186 Rest of Asia Pacific Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 187 Rest of Asia Pacific Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 188 Rest of Asia Pacific Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 189 LAMEA Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 190 LAMEA Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 191 LAMEA Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 192 LAMEA Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 193 LAMEA Type 2 Diabetes Market by Country, 2019 - 2022, USD Thousands
• TABLE 194 LAMEA Type 2 Diabetes Market by Country, 2023 - 2030, USD Thousands
• TABLE 195 LAMEA Type 1 Diabetes Market by Country, 2019 - 2022, USD Thousands
• TABLE 196 LAMEA Type 1 Diabetes Market by Country, 2023 - 2030, USD Thousands
• TABLE 197 LAMEA Prediabetes Market by Country, 2019 - 2022, USD Thousands
• TABLE 198 LAMEA Prediabetes Market by Country, 2023 - 2030, USD Thousands
• TABLE 199 LAMEA Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 200 LAMEA Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 201 LAMEA Hospitals & Diabetic Care Center Market by Country, 2019 - 2022, USD Thousands
• TABLE 202 LAMEA Hospitals & Diabetic Care Center Market by Country, 2023 - 2030, USD Thousands
• TABLE 203 LAMEA Diagnostic Laboratory Market by Country, 2019 - 2022, USD Thousands
• TABLE 204 LAMEA Diagnostic Laboratory Market by Country, 2023 - 2030, USD Thousands
• TABLE 205 LAMEA Others Market by Country, 2019 - 2022, USD Thousands
• TABLE 206 LAMEA Others Market by Country, 2023 - 2030, USD Thousands
• TABLE 207 LAMEA Glycated Albumin Assay Market by Country, 2019 - 2022, USD Thousands
• TABLE 208 LAMEA Glycated Albumin Assay Market by Country, 2023 - 2030, USD Thousands
• TABLE 209 Brazil Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 210 Brazil Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 211 Brazil Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 212 Brazil Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 213 Brazil Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 214 Brazil Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 215 Argentina Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 216 Argentina Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 217 Argentina Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 218 Argentina Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 219 Argentina Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 220 Argentina Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 221 UAE Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 222 UAE Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 223 UAE Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 224 UAE Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 225 UAE Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 226 UAE Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 227 Saudi Arabia Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 228 Saudi Arabia Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 229 Saudi Arabia Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 230 Saudi Arabia Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 231 Saudi Arabia Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 232 Saudi Arabia Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 233 South Africa Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 234 South Africa Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 235 South Africa Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 236 South Africa Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 237 South Africa Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 238 South Africa Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 239 Nigeria Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 240 Nigeria Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 241 Nigeria Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 242 Nigeria Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 243 Nigeria Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 244 Nigeria Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 245 Rest of LAMEA Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
• TABLE 246 Rest of LAMEA Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
• TABLE 247 Rest of LAMEA Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
• TABLE 248 Rest of LAMEA Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
• TABLE 249 Rest of LAMEA Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
• TABLE 250 Rest of LAMEA Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
• TABLE 251 Key Information - Asahi Kasei Pharma Corporation
• TABLE 252 Key Information - EKF Diagnostics Holdings plc
• TABLE 253 Key Information - Weldon Biotech India Private Limited
• TABLE 254 Key Information - Hzymes Biotechnology Co., Ltd.
• TABLE 255 Key Information - Beijing Strong Biotechnologies, Inc.
• TABLE 256 Key Information - Abbexa Limited
• TABLE 257 Key Information - Biomatik Corporation
• TABLE 258 Key Information - Abnova Corporation
• TABLE 259 Key Information - Geno Technology, Inc.
• TABLE 260 Key Information - Diazyme Laboratories, Inc.

List of Figures

• FIG 1 Methodology for the research
• FIG 2 Global Glycated Albumin Assay Market, 2019 - 2030, USD Thousands
• FIG 3 Key Factors Impacting the Glycated Albumin Assay Market
• FIG 4 Porter's Five Forces Analysis - Glycated Albumin Assay Market
• FIG 5 Global Glycated Albumin Assay Market share by Application, 2022
• FIG 6 Global Glycated Albumin Assay Market share by Application, 2030
• FIG 7 Global Glycated Albumin Assay Market by Application, 2019 - 2030, USD Thousands
• FIG 8 Global Glycated Albumin Assay Market share by End User, 2022
• FIG 9 Global Glycated Albumin Assay Market share by End User, 2030
• FIG 10 Global Glycated Albumin Assay Market by End User, 2019 - 2030, USD Thousands
• FIG 11 Global Glycated Albumin Assay Market share by Region, 2022
• FIG 12 Global Glycated Albumin Assay Market share by Region, 2030
• FIG 13 Global Glycated Albumin Assay Market by Region, 2019 - 2030, USD Thousands
• FIG 14 SWOT Analysis: Asahi Kasei Pharma Corporation
• FIG 15 SWOT Analysis: EKF Diagnostics Holdings plc
• FIG 16 SWOT Analysis: Weldon Biotech India Private Limited
• FIG 17 SWOT Analysis: Beijing Strong Biotechnologies, Inc.
• FIG 18 SWOT Analysis: Abbexa Limited
• FIG 19 SWOT Analysis: Biomatik Corporation
• FIG 20 SWOT Analysis: Abnova Corporation
• FIG 21 SWOT Analysis: Geno Technology, Inc.
• FIG 22 SWOT Analysis: Diazyme Laboratories, Inc.

The Global Glycated Albumin Assay Market size is expected to reach $384.5 million by 2030, rising at a market growth of 8.4% CAGR during the forecast period.

The WHO reports that healthcare spending reached a record high of US $9 trillion (about 11% of global GDP) due to substantial increase in healthcare spending by governments at all income levels. Thus, the Hospitals & Diabetic Care Center segment will capture more than 40% share in the market by 2030, due to the increasing number & size of investments invested in the healthcare industry by governments of different nations. Because of their rapid economic development and rising healthcare expenses, it is projected that more developing countries would have more access to high-quality healthcare. Some of the factors impacting the market are increasing diabetes prevalence, growing ageing population, and the evolving regulatory environment.

Due to pancreatic malfunction concerning insulin, diabetes is a frequent chronic metabolic condition. Uncontrolled diabetes frequently has the side effect of hyperglycemia, also known as elevated blood glucose or blood sugar. Blood arteries and nerves are particularly vulnerable to significant damage from diabetes. The market benefits from the rising prevalence of diabetes. The rising incidence of diabetes results from the rising prevalence of obesity. Diabetes death rates by age increased by 3% between 2000 and 2019. The death rate from diabetes climbed 13% in lower-middle-income nations. Additionally, The WHO reports that people are living longer overall. The majority of people today likely plan to live until their sixties and beyond. By 2030, one in six people will be 60 years of age or older. There will be 2.1 billion people worldwide who are 60 years of age or older by 2050. The old aged population is more at a risk of conditions such as type 2 diabetes and type 1 diabetes. Thus, the need for glycated albumin assay will rise due to the increase in diabetes prevalence and people live longer and endure more severe problems like diabetes.

Furthermore, the COVID-19 pandemic had a significant negative effect on the global economy. Almost every industry has been impacted by the pandemic, either positively or negatively. In the initial stages of the pandemic outbreak, the market experienced a modest impact. Due to the regulatory authorities' stringent enforcement of lockdown and shutdown orders and increased viruses that restricted people from moving freely from one location to another and restricted them to attend hospitals for routine checkups, market growth has decreased. This halted the growth of market during the initial months of pandemic.

However, Both the American Diabetes Association (ADA) and the European Association of Diabetes Study (EASD) advocate "patient-centered" management of glycemic control in people with Type 2 Diabetes Mellitus (T2DM) and the use of only those biomarkers, such as GA that accurately reflect the individual health status of the diabetic patient while maintaining a balance between risks and benefits. Device makers face a significant obstacle in expanding this market since they are required by US federal rules to submit a 510(k) application for any additional modifications to a device. The market may face difficulties due to significant regulatory landscape changes.

Application Outlook

Based on the application, the market is segmented into prediabetes, type 1 diabetes, and type 2 diabetes. The prediabetes segment acquired a substantial revenue share in the market in 2022. Blood glucose levels which rise above normal but not high enough to be categorized as diabetes are called prediabetes. Early detection of prediabetes is crucial in order to undertake changes in lifestyle and therapies to prevent or postpone the onset of type 2 diabetes. Compared to some other tests, such the HbA1c, which offers an average over the past three months, the glycated albumin assay

End User

By end user, the market is classified into hospital & diabetes care centers, diagnostic laboratories, and Others. In 2022, the hospital & diabetes care centers segment held the highest revenue share in the market. This segment has experienced tremendous market expansion, mostly due to a greater focus on early disease diagnosis. Hospitals and organizations for diabetes care are also dedicated to giving patients care tailored to people with diabetes. Glycated albumin assays, a crucial diagnostic test for tracking glycemic control, are frequently performed in these centers due to their emphasis on comprehensive diabetes care.

Regional Outlook

Region wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region registered the highest revenue share in the market. The rising incidence of lifestyle disorders like diabetes and helpful government programs for efficient diabetes treatment is responsible for expanding the North American market. The area's Medicaid, Medicare, and commercial health insurance firms are also anticipated to significantly contribute to the market growth by expanding their healthcare coverage. Other market expansion drivers include an aging population, the introduction of beneficial government policies, and more sophisticated assays.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Asahi Kasei Pharma Corporation (Asahi Kasei Corporation), EKF Diagnostics Holdings plc, Weldon Biotech India Private Limited, Hzymes Biotechnology Co., Ltd., Beijing Strong Biotechnologies, Inc., Diazyme Laboratories, Inc. (General Atomics), Abbexa Limited, Biomatik Corporation, Abnova Corporation and Geno Technology, Inc.

Scope of the Study

Market Segments covered in the Report:

By Application

• Type 2 Diabetes
• Type 1 Diabetes
• Prediabetes

By End User

• Hospitals & Diabetic Care Center
• Diagnostic Laboratory
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Asahi Kasei Pharma Corporation (Asahi Kasei Corporation)
• EKF Diagnostics Holdings plc
• Weldon Biotech India Private Limited
• Hzymes Biotechnology Co., Ltd.
• Beijing Strong Biotechnologies, Inc.
• Diazyme Laboratories, Inc. (General Atomics)
• Abbexa Limited
• Biomatik Corporation
• Abnova Corporation
• Geno Technology, Inc.

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Glycated Albumin Assay Market, by Application
  • 1.4.2 Global Glycated Albumin Assay Market, by End User
  • 1.4.3 Global Glycated Albumin Assay Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market At a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
• 3.3 Porter Five Forces Analysis

Chapter 4. Global Glycated Albumin Assay Market by Application

• 4.1 Global Type 2 Diabetes Market by Region
• 4.2 Global Type 1 Diabetes Market by Region
• 4.3 Global Prediabetes Market by Region

Chapter 5. Global Glycated Albumin Assay Market by End User

• 5.1 Global Hospitals & Diabetic Care Center Market by Region
• 5.2 Global Diagnostic Laboratory Market by Region
• 5.3 Global Others Market by Region

Chapter 6. Global Glycated Albumin Assay Market by Region

• 6.1 North America Glycated Albumin Assay Market
  • 6.1.1 North America Glycated Albumin Assay Market by Application
    • 6.1.1.1 North America Type 2 Diabetes Market by Country
    • 6.1.1.2 North America Type 1 Diabetes Market by Country
    • 6.1.1.3 North America Prediabetes Market by Country
  • 6.1.2 North America Glycated Albumin Assay Market by End User
    • 6.1.2.1 North America Hospitals & Diabetic Care Center Market by Country
    • 6.1.2.2 North America Diagnostic Laboratory Market by Country
    • 6.1.2.3 North America Others Market by Country
  • 6.1.3 North America Glycated Albumin Assay Market by Country
    • 6.1.3.1 US Glycated Albumin Assay Market
      • 6.1.3.1.1 US Glycated Albumin Assay Market by Application
      • 6.1.3.1.2 US Glycated Albumin Assay Market by End User
    • 6.1.3.2 Canada Glycated Albumin Assay Market
      • 6.1.3.2.1 Canada Glycated Albumin Assay Market by Application
      • 6.1.3.2.2 Canada Glycated Albumin Assay Market by End User
    • 6.1.3.3 Mexico Glycated Albumin Assay Market
      • 6.1.3.3.1 Mexico Glycated Albumin Assay Market by Application
      • 6.1.3.3.2 Mexico Glycated Albumin Assay Market by End User
    • 6.1.3.4 Rest of North America Glycated Albumin Assay Market
      • 6.1.3.4.1 Rest of North America Glycated Albumin Assay Market by Application
      • 6.1.3.4.2 Rest of North America Glycated Albumin Assay Market by End User
• 6.2 Europe Glycated Albumin Assay Market
  • 6.2.1 Europe Glycated Albumin Assay Market by Application
    • 6.2.1.1 Europe Type 2 Diabetes Market by Country
    • 6.2.1.2 Europe Type 1 Diabetes Market by Country
    • 6.2.1.3 Europe Prediabetes Market by Country
  • 6.2.2 Europe Glycated Albumin Assay Market by End User
    • 6.2.2.1 Europe Hospitals & Diabetic Care Center Market by Country
    • 6.2.2.2 Europe Diagnostic Laboratory Market by Country
    • 6.2.2.3 Europe Others Market by Country
  • 6.2.3 Europe Glycated Albumin Assay Market by Country
    • 6.2.3.1 Germany Glycated Albumin Assay Market
      • 6.2.3.1.1 Germany Glycated Albumin Assay Market by Application
      • 6.2.3.1.2 Germany Glycated Albumin Assay Market by End User
    • 6.2.3.2 UK Glycated Albumin Assay Market
      • 6.2.3.2.1 UK Glycated Albumin Assay Market by Application
      • 6.2.3.2.2 UK Glycated Albumin Assay Market by End User
    • 6.2.3.3 France Glycated Albumin Assay Market
      • 6.2.3.3.1 France Glycated Albumin Assay Market by Application
      • 6.2.3.3.2 France Glycated Albumin Assay Market by End User
    • 6.2.3.4 Russia Glycated Albumin Assay Market
      • 6.2.3.4.1 Russia Glycated Albumin Assay Market by Application
      • 6.2.3.4.2 Russia Glycated Albumin Assay Market by End User
    • 6.2.3.5 Spain Glycated Albumin Assay Market
      • 6.2.3.5.1 Spain Glycated Albumin Assay Market by Application
      • 6.2.3.5.2 Spain Glycated Albumin Assay Market by End User
    • 6.2.3.6 Italy Glycated Albumin Assay Market
      • 6.2.3.6.1 Italy Glycated Albumin Assay Market by Application
      • 6.2.3.6.2 Italy Glycated Albumin Assay Market by End User
    • 6.2.3.7 Rest of Europe Glycated Albumin Assay Market
      • 6.2.3.7.1 Rest of Europe Glycated Albumin Assay Market by Application
      • 6.2.3.7.2 Rest of Europe Glycated Albumin Assay Market by End User
• 6.3 Asia Pacific Glycated Albumin Assay Market
  • 6.3.1 Asia Pacific Glycated Albumin Assay Market by Application
    • 6.3.1.1 Asia Pacific Type 2 Diabetes Market by Country
    • 6.3.1.2 Asia Pacific Type 1 Diabetes Market by Country
    • 6.3.1.3 Asia Pacific Prediabetes Market by Country
  • 6.3.2 Asia Pacific Glycated Albumin Assay Market by End User
    • 6.3.2.1 Asia Pacific Hospitals & Diabetic Care Center Market by Country
    • 6.3.2.2 Asia Pacific Diagnostic Laboratory Market by Country
    • 6.3.2.3 Asia Pacific Others Market by Country
  • 6.3.3 Asia Pacific Glycated Albumin Assay Market by Country
    • 6.3.3.1 China Glycated Albumin Assay Market
      • 6.3.3.1.1 China Glycated Albumin Assay Market by Application
      • 6.3.3.1.2 China Glycated Albumin Assay Market by End User
    • 6.3.3.2 Japan Glycated Albumin Assay Market
      • 6.3.3.2.1 Japan Glycated Albumin Assay Market by Application
      • 6.3.3.2.2 Japan Glycated Albumin Assay Market by End User
    • 6.3.3.3 India Glycated Albumin Assay Market
      • 6.3.3.3.1 India Glycated Albumin Assay Market by Application
      • 6.3.3.3.2 India Glycated Albumin Assay Market by End User
    • 6.3.3.4 South Korea Glycated Albumin Assay Market
      • 6.3.3.4.1 South Korea Glycated Albumin Assay Market by Application
      • 6.3.3.4.2 South Korea Glycated Albumin Assay Market by End User
    • 6.3.3.5 Singapore Glycated Albumin Assay Market
      • 6.3.3.5.1 Singapore Glycated Albumin Assay Market by Application
      • 6.3.3.5.2 Singapore Glycated Albumin Assay Market by End User
    • 6.3.3.6 Malaysia Glycated Albumin Assay Market
      • 6.3.3.6.1 Malaysia Glycated Albumin Assay Market by Application
      • 6.3.3.6.2 Malaysia Glycated Albumin Assay Market by End User
    • 6.3.3.7 Rest of Asia Pacific Glycated Albumin Assay Market
      • 6.3.3.7.1 Rest of Asia Pacific Glycated Albumin Assay Market by Application
      • 6.3.3.7.2 Rest of Asia Pacific Glycated Albumin Assay Market by End User
• 6.4 LAMEA Glycated Albumin Assay Market
  • 6.4.1 LAMEA Glycated Albumin Assay Market by Application
    • 6.4.1.1 LAMEA Type 2 Diabetes Market by Country
    • 6.4.1.2 LAMEA Type 1 Diabetes Market by Country
    • 6.4.1.3 LAMEA Prediabetes Market by Country
  • 6.4.2 LAMEA Glycated Albumin Assay Market by End User
    • 6.4.2.1 LAMEA Hospitals & Diabetic Care Center Market by Country
    • 6.4.2.2 LAMEA Diagnostic Laboratory Market by Country
    • 6.4.2.3 LAMEA Others Market by Country
  • 6.4.3 LAMEA Glycated Albumin Assay Market by Country
    • 6.4.3.1 Brazil Glycated Albumin Assay Market
      • 6.4.3.1.1 Brazil Glycated Albumin Assay Market by Application
      • 6.4.3.1.2 Brazil Glycated Albumin Assay Market by End User
    • 6.4.3.2 Argentina Glycated Albumin Assay Market
      • 6.4.3.2.1 Argentina Glycated Albumin Assay Market by Application
      • 6.4.3.2.2 Argentina Glycated Albumin Assay Market by End User
    • 6.4.3.3 UAE Glycated Albumin Assay Market
      • 6.4.3.3.1 UAE Glycated Albumin Assay Market by Application
      • 6.4.3.3.2 UAE Glycated Albumin Assay Market by End User
    • 6.4.3.4 Saudi Arabia Glycated Albumin Assay Market
      • 6.4.3.4.1 Saudi Arabia Glycated Albumin Assay Market by Application
      • 6.4.3.4.2 Saudi Arabia Glycated Albumin Assay Market by End User
    • 6.4.3.5 South Africa Glycated Albumin Assay Market
      • 6.4.3.5.1 South Africa Glycated Albumin Assay Market by Application
      • 6.4.3.5.2 South Africa Glycated Albumin Assay Market by End User
    • 6.4.3.6 Nigeria Glycated Albumin Assay Market
      • 6.4.3.6.1 Nigeria Glycated Albumin Assay Market by Application
      • 6.4.3.6.2 Nigeria Glycated Albumin Assay Market by End User
    • 6.4.3.7 Rest of LAMEA Glycated Albumin Assay Market
      • 6.4.3.7.1 Rest of LAMEA Glycated Albumin Assay Market by Application
      • 6.4.3.7.2 Rest of LAMEA Glycated Albumin Assay Market by End User

Chapter 7. Company Profiles

• 7.1 Asahi Kasei Pharma Corporation (Asahi Kasei Corporation)
  • 7.1.1 Company Overview
  • 7.1.2 SWOT Analysis
  • 7.1.3 Financial Analysis
  • 7.1.4 Segmental and Regional Analysis
  • 7.1.5 Research & Development Expenses
• 7.2 EKF Diagnostics Holdings plc
  • 7.2.1 Company Overview
  • 7.2.2 Financial Analysis
  • 7.2.3 Segmental and Regional Analysis
  • 7.2.4 Research & Development Expenses
  • 7.2.5 SWOT Analysis
• 7.3 Weldon Biotech India Private Limited
  • 7.3.1 Company Overview
  • 7.3.2 SWOT Analysis
• 7.4 Hzymes Biotechnology Co., Ltd.
  • 7.4.1 Company Overview
• 7.5 Beijing Strong Biotechnologies, Inc.
  • 7.5.1 Company Overview
  • 7.5.2 SWOT Analysis
• 7.6 Abbexa Limited
  • 7.6.1 Company Overview
  • 7.6.2 SWOT Analysis
• 7.7 Biomatik Corporation
  • 7.7.1 Company Overview
  • 7.7.2 SWOT Analysis
• 7.8 Abnova Corporation
  • 7.8.1 Company Overview
  • 7.8.2 SWOT Analysis
• 7.9 Geno Technology, Inc.
  • 7.9.1 Company Overview
  • 7.9.2 SWOT Analysis
• 7.10. Diazyme Laboratories, Inc. (General Atomics)
  • 7.10.1 Company Overview
  • 7.10.2 Recent strategies and developments:
    • 7.10.2.1 Partnerships, Collaborations, and Agreements:
  • 7.10.3 SWOT Analysis

Chapter 8. Winning Imperative for Glycated Albumin Assay Market